CoChat

Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes

Open access
Khairani, Candrika D., Bejjani, Antoine, Piazza, Gregory, Jimenez, David, Monreal, Manuel, Chatterjee, Saurav, Pengo, Vittorio, Woller, Scott C., Cortes-Hernandez, Josefina, Connors, Jean M., Kanthi, Yogendra, Krumholz, Harlan M., Middeldorp, Saskia, Falanga, Anna, Cushman, Mary, Goldhaber, Samuel Z., Garcia, David A., Bikdeli, Behnood · 2023 · Journal of the American College of Cardiology
Cited by 172

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Background: The efficacy and safety of direct oral anticoagulants (DOACs) for patients with thrombotic antiphospholipid syndrome (APS) remain controversial. Objectives: We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) that compared DOACs with vitamin-K antagonists (VKAs). Methods: We searched PubMed, EMBASE, and Cochrane Central Register of Controlled Trials through April 9, 2022. The two main efficacy outcomes were a composite of arterial thrombotic events, and venous thromboembolic events (VTE). The main safety outcome was major bleeding. Random effects models with inverse variance were used. Results: Our search retrieved 253 studies. Four open-label RCTs involving 472 patients were included (mean control-arm time-in-therapeutic-range: 60%). All had proper random sequence generation and adequate allocation concealment. Overall, use of DOACs compared with VKAs was associated with increased odds of subsequent arterial thrombotic events (OR 5.43, 95% confidence interval [CI] 1.87–15.75, p < 0.001, I2 = 0%), especially stroke, and composite of arterial thrombotic events or VTE (OR 4.46, 95% CI 1.12–17.84, p = 0.03, I2 = 0%). The odds of subsequent VTE (OR 1.20, 95% CI 0.31–4.55, p = 0.79, I2 = 0%), or major bleeding (OR 1.02, 95% CI 0.42–2.47, p = 0.97, I2 = 0%) were not significantly different between the two groups. Most findings were consistent within subgroups. Conclusions: Patients with thrombotic APS randomized to DOACs compared to VKAs appear to have increased risk for arterial thrombosis. No significant differences were observed between patients randomized to DOACs vs VKAs in the risk of subsequent VTE or major bleeding.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2022.10.008

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 172

Metadata

Authors
Khairani, C. D., Bejjani, A., Piazza, G., Jimenez, D., Monreal, M., Chatterjee, S., Pengo, V., Woller, S. C., Cortes-Hernandez, J., Connors, J. M., Kanthi, Y., Krumholz, H. M., Middeldorp, S., Falanga, A., Cushman, M., Goldhaber, S. Z., Garcia, D. A., & Bikdeli, B.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2023-01
Volume
81
Issue
1
Pages
16-30
ISSN
0735-1097 (ISSN-L)
OpenAlex
W4307684607
Cited by
172
References
24
FWCI
20.98
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes. https://app.cochat.ai/papers/10.1016/j.jacc.2022.10.008
The paper
Khairani, C. D., Bejjani, A., Piazza, G., Jimenez, D., Monreal, M., Chatterjee, S., Pengo, V., Woller, S. C., Cortes-Hernandez, J., Connors, J. M., Kanthi, Y., Krumholz, H. M., Middeldorp, S., Falanga, A., Cushman, M., Goldhaber, S. Z., Garcia, D. A., & Bikdeli, B. (2023). Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2022.10.008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.